30
June
2022


Share on networks

The INTEL technology company will open a microchip design laboratory together with the Barcelona Supercomputation Center (BSC-CNS) to help Europe become autonomous in chips with technology based on open-source RISC-V hardware. These chips are used worldwide in the design of autonomous cars or devices for artificial intelligence applications, and their manufacture is crucial, especially in the current context of the supply crisis.

This laboratory will receive an investment from INTEL of 200 million euros over 10 years, plus another 200 million euros from the government. This investment will place the country at the forefront of a key sector of the economy and is expected to generate 300 jobs.

Mateo Valero, director of BSC-CNS, confirmed that the agreement was formalized in Davos between the President of the Government, Pedro Sánchez, and the CEO of Intel, Pat Gelsinger:

In addition, Valero is convinced that the existence of this laboratory in Barcelona, in such a competitive market, where competition is enormous and where Europe does not produce anything, will help to create a hub for new companies and jobs.

Natàlia Mas, Director General of Industry of the Generalitat de Catalunya and Director General of Catalonia Trade & Investment, reaffirms this, pointing out that: “The fact that INTEL is establishing itself in Barcelona with a project as strategic as the microchips is another example of why Catalonia is one of the most dynamic territories in Europe in terms of attracting foreign investment of a technological and productive nature”.

Share on networks

Related news

El 22@ consolida la seva recuperació i tanca 2024 doblant la contractació d’oficines

News

22@ district consolidates recovery and doubles office space leasing by the end of 2024

Invertirà 13 milions en les seves noves instal·lacions per a malalties infeccioses

News

Biotechnology company Qiagen establishes its global innovation centre in Esplugues

La plataforma Deeplabs invertirà 70 milions en el seu campus biomèdic de Barcelona

News

Deeplabs to invest €70 million in its biomedical campus in Barcelona

Bayer obre a Barcelona una nova àrea d’R+D en salut i agricultura amb 82 nous professionals

News

Bayer opens a new R&D division for health and agriculture in Barcelona with 82 new professionals